Investors buying into the IPO of small-cap medical device distributor Lifehealthcare on Thursday see an opportunity to gain exposure to defensive earnings in...

Livewire Equities

Livewire

Investors buying into the IPO of small-cap medical device distributor Lifehealthcare on Thursday see an opportunity to gain exposure to defensive earnings in the healthcare sector at a good price. Lifehealthcare will list with a market capitalisation of about $85 million after raising over $76 million. Jack Collopy of Perpetual said the company was attractively priced, offered strong dividend yield and had a solid balance sheet. Perpetual had taken a small position in its micro-cap fund. Mr Collopy said they could not offer investors hard assets or strong IP, but on the flipside it also escaped potential cost blow-outs associated with research and development. There's some positives and negatives to having healthcare exposure but without the specific products, he said. Investors Mutual equity analyst Daniel Moore said attractive qualities of the IPO included the potential to consolidate the fragmented distribution sector, as well as a capable salesforce. Read more: (VIEW LINK)


Livewire Equities
Livewire Equities
Livewire

The Livewire Equities feed brings you a range of insights that relate to Australian equities

Expertise

No areas of expertise

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.